4215 5 (Onglyza 5 mg)
Generic Name: saxagliptin
Pill with imprint 4215 5 is Pink, Round and has been identified as Onglyza 5 mg. It is supplied by Bristol-Myers Squibb.
Onglyza is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4215 5
Onglyza
- Generic Name
- saxagliptin
- Imprint
- 4215 5
- Strength
- 5 mg
- Color
- Pink
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-4215 | |
| 00310-6105 | AstraZeneca |
Related Images for "4215 5"
More about Onglyza (saxagliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 15 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
